Members of the Committee, which currently consist of BA Value Investors LLC, a private investment firm founded by Steven N. Bronson, and ROI Capital Management, a registered investment advisor managed by
Mark T. Boyer and Mitchell J. Soboleski, collectively own 13.7 % of the
outstanding common
stock of VaxGen.